Observational studies on prophylaxis of hepatitis B virus reactivation with long or short course oralAgents among patients with acute myeloidleukemia
Journal Title: Preventive Medicine Research - Year 2014, Vol 3, Issue 1
Abstract
Background and purpose:hepatitis B virus (HBV) reactivation is one of serious complications among patients with acute myeloid LeukeMia (AML) following cytotoxic induction and consolidation chemotherapy.Nucleoside analogs including lamivudine and entecavir have been widely used as prophylactic or preemptive treatment for HBV reactivation.This study is to investigate clinical efficacy and safety of a long or short course oral ANTI-HBV for agents HBV reactivation in AML patients with HBV infection during chemotherapy.Methods:themedical records AML patients with HBV infection receiving aT least 4 courses of chemotherapy were Fund-funded:Department of theNineth People's Hospital affiliated to Shanghai Jiaotong University Medical School Fusion Fund(yard Fusion2017)Communications Author:LiuYanE-mail:ybb539355@163. com The retrospectively identified and systematically analyzed.These patients were further divided into four groups according to their hepatitis B surface antigen (HBsAg) status prior to initiation of chemotherapy and duration of prophylactic therapy.Reactivation of HBV and toxicity profiles of oral antiviral agents were systematically analyzed and compared among differeNT groups. Results:HBV reactivation and documented hbv-related hepatitis were Significantly lower in AML patients under long course antiviral prophylaxis (i.e. continuing oral antiviral therapy for at least 6 months after cessation of chemotherapy, LCP group) than in the patients with short course antiviral (i.e. continuing oral antiviral therapy for one month after cessation of chemotherapy, SCP Group), which was 5.56% (1/18) And0%(0/18) compared with 45.45% (5/11) and 36.36% (4/11) (p=0.018 and p=0.014). There was little difference in the incidence of antiviral resistance between LCP and SCP groups [11.11% (2/18) V5 9.09% (1/11), p>0.05].Furthermore, the rates of HBV reactivation and hbv-related hepatitis were significantly lower in AML patients with PositivE-HBsAg (HBsAg ^0.05 iu/ml) under long course antiviral prophylaxis than in HBsAg positive patients who received short couRSE antiviral agents [8.33% (1/12) and0%(0/12) V5 66.67% (4/6) and 66.67% (4/6), p=0.022 and p=0.005].Meanwhile, there was little difference in the rates of antiviral resistance-LCP and SCP between groups HBsAg amonge patients [8.33% (1/12) V5 16.67% (1/6), p>0.05].In addition, the rates of HBV reactivation and hbv-related hepatitis as so as antiviral resistance were shown to have LiTtle difference in AML patients with negative HBsAg (hbsag<0.05 iu/ml) between LCP and SCP groups.Concerning antiviral agent toxicity, no grade 3-4 toxicity occurred in patients from LCP or SCP group.Conclusion:Long course prophylaxis with oral antiviral agent appears to be an effective and tolerated preventative approach for reducing risks of HBV reactivation and associated events in AML pAtients with positive HBsAg during chemotherapy, which serves as a platform for the design of prospective clinical.
Authors and Affiliations
Zhuang yan, Tang yong, Yu yehua, Hang haifang, Ye weide Liu juan
Keywords
Related Articles
- EP ID EP680360
- DOI -
- Views 151
- Downloads 0
Prevention and treatment of liver injury induced by fluconazole by 27-flavor pill with Mongolian medicine
Purpose:to observe the clinical efficacy and preventive effect of 27-flavour pill of Mongolian medicine and liver in patients with liver injury caused by fluconazole. method:gather for fungal infections use patients with...
Community prevention and treatment of chronic hypertension
Explore the effectiveness of community-based prevention and treatment for chronic hypertension. method to this community 2014 year 3 month~2017 Year 3 month period,Patients with chronic hypertension are the object of stu...
Iof efficacy and safety of anticoagulant therapy for preventing Secondary thromboembolic disease in hypertensive Cerebral hemorrhage
Objective To evaluate the efficacy and safety of early anticoagulant treatment for preventing secondary thromboembolic Disease in hypertensive intra-cerebral hemorrhage. Methods cases of hypertensive cerebral hemorrhage...
Prevention and treatment of bacterial disease in cattle line
the pathogen of bovine line fungus disease,Epidemiology,Clinical disease Shape,PathologyChange,Diagnostic methods and prevention measures were presenteddescribed,to be broadLarge cattle-raising people to prevent and trea...
Observational studies on prophylaxis of hepatitis B virus reactivation with long or short course oralAgents among patients with acute myeloidleukemia
Background and purpose:hepatitis B virus (HBV) reactivation is one of serious complications among patients with acute myeloid LeukeMia (AML) following cytotoxic induction and consolidation chemotherapy.Nucleoside analogs...